news - International Biopharmaceutical Industry

Current Edition

news

Cannabics Pharma clinches clinical trial on Cannabics SR 5mg for CACS

The company is awaiting for the results and expect them to further clarify an important part of their mission in integrating cannabinoid-based therapies into the wo...

6 July 2018 news CACS | cannabics

Continue Reading →

news

Blood test to determine best timing to administer drugs

The team based its research on the fact that the efficacy of drugs changes depending on what time of day they are administered. A team of researchers at the Charit...

6 July 2018 news administer | best

Continue Reading →

news

AHH raises $50 million from Sheares Healthcare

AHH to leverage expertise of leading healthcare executives and investors to transform specialty healthcare in South Asia Asia Healthcare Holdings (AHH), an operating...

6 July 2018 news $50M | AHH

Continue Reading →

news

Napier launches AI/ML powered healthcare assistant

The Napier Assistant will be available to work with any third-party application to empower key users such as doctors and nurses. Leading Singapore-based healthcare ...

6 July 2018 news AI/ML | assistant

Continue Reading →

news

HUMAN VACCINES PROJECT AND SEQIRUS PARTNER TO ADVANCE UNIVERSAL FLU VACCINE RESEARCH

The Human Vaccines Project, a nonprofit public-private partnership focused on decoding the immune system to improve human health, and Seqirus, a global leader in the ...

5 July 2018 news advance | human

Continue Reading →

news

PharmaMar, Chugai terminate License Agreement for Zepsyre

PharmaMar announces that both Chugai and PharmaMar have entered into a mutual early termination agreement of this license agreement Chugai Pharmaceutical Co., Ltd. ...

29 June 2018 news agreement | chugai

Continue Reading →

news

Plasticell leads gene therapy manufacturing consortium

UK’s innovation agency provides funding to develop advanced technologies for the manufacturing of autologous ex vivo gene therapies. Plasticell, a developer of st...

29 June 2018 news consortium | gene

Continue Reading →

news

NBE Therapeutics Closes a CHF 20 Million Financing by Novo Holdings A/S

NBE Therapeutics AG, a biopharmaceutical company developing next-generation antibody-drug conjugates (ADCs) for improved cancer therapy, today announces a CHF 20 mill...

29 June 2018 news 20 | CHF

Continue Reading →

news

Prestige Biopharma and Alvogen Announce License and Supply Agreement to Commercialize Prestige´s Trastuzumab Biosimilar (Hervelous™) in Central and Eastern Europe Singapore

Prestige BioPharma and Alvogen today announced that the two companies have entered into a binding agreement for the exclusive partnership and supply for the commercia...

29 June 2018 news alvogen | announce

Continue Reading →

news

Immunotherapy advances spur new look at cancer vaccines

In an era of cancer immunotherapy, vaccines are getting fresh consideration as a therapeutic approach. Frustrated for years by lackluster results, cancer vaccine res...

29 June 2018 news advances | cancer

Continue Reading →